These mechanisms in the brain are of particular interest for understanding the ability of A2AR antagonists or A2AR gene deletion to remove tumor-induced immunosuppression from tumor-reactive CD8+ T cells (17, 18). The gene discussed is CD8A; the disease is neoplasm.